Biocept, Inc

(NASDAQ:BIOC)

Latest On Biocept, Inc (BIOC):

Date/Time Type Description Signal Details
2023-05-25 04:28 ESTNewsBiocept stock surges on pricing $5.0M stock offeringN/A
2023-05-17 14:47 ESTNewsBiocept undertakes 1-for-30 reverse stock splitN/A
2023-05-11 02:39 ESTNewsBiocept GAAP EPS of -$0.41, revenue of $0.7M misses by $0.88MN/A
2023-04-18 07:53 ESTNewsBiocept GAAP EPS of -$1.89 misses by $0.84, revenue of $25.9M beats by $18.65MN/A
2023-03-24 23:37 ESTNewsBiocept stock pops as enrollment starts in trial of cancer detection test CNSideN/A
2023-01-06 09:44 ESTNewsBiocept explores strategic alternatives, to cut workforce by 35%N/A
2022-11-29 02:44 ESTNewsBiocept GAAP EPS of -$0.33 beats by $0.03, revenue of $5.59M beats by $1.3MN/A
2022-11-29 02:43 ESTNewsBiocept, Inc. (BIOC) Q3 2022 Earnings Call TranscriptN/A
2022-11-21 23:20 ESTNewsBiocept GAAP EPS of -$0.04 beats by $0.27, revenue of $5.59M misses by $2.27MN/A
2022-11-11 07:00 ESTNewsBiocept GAAP EPS of -$0.31, revenue of $10.6MN/A
2022-06-22 16:27 ESTNewsPlus Therapeutics inks contract to use Biocept's test for use in cancer trialN/A
2022-05-24 15:07 ESTNewsBiocept GAAP EPS of -$0.16 beats by $0.08, revenue of $19.95M beats by $8.46MN/A
2022-05-17 04:06 ESTNewsBiocept reports delay in filing of Q1 report on Form 10-QN/A
2022-04-01 03:31 ESTNewsBiocept reports FY resultsN/A
2022-03-31 07:43 ESTNewsBiocept Q4 Earnings PreviewN/A
2022-03-08 10:11 ESTNewsBiocept taps veteran biotechnology executive as COON/A
2022-02-17 11:37 ESTNewsBiocept appoints Samuel Riccitelli as interim president, CEON/A
2022-01-22 00:10 ESTNewsBiocept reports increase in COVID-19 RT-PCR testing due to OmicronN/A
2021-11-22 20:13 ESTNewsBiocept launches combined COVID-19 and influenza testN/A
2021-11-15 21:40 ESTNewsBiocept EPS misses by $0.04, beats on revenueN/A
2021-11-15 21:39 ESTNewsBiocept, Inc. (BIOC) CEO Michael Nall on Q3 2021 Results - Earnings Call TranscriptN/A
2021-08-17 09:50 ESTNewsBiocept EPS beats by $0.02, beats on revenueN/A
2021-08-17 09:50 ESTNewsBiocept, Inc. (BIOC) CEO Michael Nall on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-22 19:56 ESTNewsBiocept receives positive coverage determination from CMS for breast cancer assayN/A
2021-07-20 21:55 ESTNewsBiocept and CLEARED4 ink collaboration agreementN/A
2021-07-20 21:45 ESTNewsBiocept shares surge on Quest Diagnostics collaboration agreementN/A
2021-07-20 21:39 ESTNewsBiocept added to Russell Microcap IndexN/A
2021-07-20 21:10 ESTNewsBiocept adds Linda Rubinstein and Antonino Morales to board of directorsN/A
2021-04-28 10:34 ESTNewsBiocept enters COVID-19 testing partnershipN/A
2021-04-12 16:54 ESTNewsBiocept: Record Revenues And Profits Support Speculative BuyN/A
2021-03-30 02:49 ESTNewsBiocept EPS beats by $0.41, beats on revenueN/A
2021-03-30 02:49 ESTNewsBiocept surges as revenue and earnings beat consensusN/A
2021-03-30 02:49 ESTNewsBiocept, Inc. (BIOC) CEO Michael Nall on Q4 2020 Results - Earnings Call TranscriptN/A
2021-03-02 08:57 ESTNewsBiocept and Aegea Biotechnologies strike supply deal for COVID-19 assay kitN/A
2021-02-23 10:59 ESTNewsBiocept and Protean Biodiagnostics to tie up in lung cancer research dealN/A
2021-01-02 15:15 ESTFinancialsCompany financials have been released.Neutral
2020-12-13 03:21 ESTFinancialsCompany financials have been released.Neutral
2020-12-11 02:42 ESTNewsBiocept's liquid biopsy shows improved accuracy for monitoring progression of metastatic breast cancerN/A
2020-11-20 15:42 ESTNewsBiocept's assays viable and sensitive for detecting tumor cells and biomarkersN/A
2020-11-18 11:16 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 11:16 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 03:18 ESTAnalyst RatingThe Analyst Target Price has decreased from $20.3 to $20.Neutral
2020-11-15 11:26 ESTFinancialsCompany financials have been released.Neutral
2020-11-13 22:27 ESTNewsBiocept, Inc. (BIOC) CEO Michael Nall on Q3 2020 Results - Earnings Call TranscriptN/A
2020-11-12 18:35 ESTNewsBiocept +4% on COVID-19 testing updateN/A
2020-11-12 18:33 ESTNewsBiocept EPS beats by $0.04, beats on revenueN/A
2020-11-01 17:18 ESTFinancialsCompany financials have been released.Neutral
2020-10-07 12:20 ESTNewsBiocept up 3% on demand for COVID-19 testN/A
2020-10-06 05:33 ESTNewsBiocept's cerebrospinal fluid test improves cancer detection compared to standard cytologyN/A
2020-09-26 15:46 ESTNewsHas the era of liquid biopsies finally arrived? Illumina thinks soN/A

About Biocept, Inc (BIOC):

Biocept, Inc., an early stage molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating tumor DNA assays utilizing a standard blood sample. The company's cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring in order to identify resistance mechanisms. It offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer, small cell lung cancer, gastric cancer, colorectal cancer, prostate cancer, melanoma, pancreaticobiliary cancer, and ovarian cancer. The company's Target-Selector molecular technology enables detection of mutations and genome alterations with enhanced sensitivity and specificity, as well as is applicable to nucleic acid from ctDNA. In addition, it offers laboratory services to medical oncologists, surgical oncologists, urologists, pulmonologists, pathologists, and other physicians to determine the treatment plan for their patients, as well as to pharmaceutical and biopharmaceutical companies developing drug candidate therapies to treat cancer. The company sells its cancer diagnostic assays directly to oncologists and other physicians at private and group practices, hospitals, laboratories, and cancer centers in the United States, as well as markets its clinical trial and research services to pharmaceutical and biopharmaceutical companies, and clinical research organizations. Biocept has research collaboration with Protean BioDiagnostics Inc. Biocept, Inc. was founded in 1997 and is headquartered in San Diego, California.

BIOC Quotes by TradingView

See Advanced Chart

General

  • Name Biocept, Inc
  • Symbol BIOC
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDiagnostics & Research
  • Full Time Employees 88
  • Last Split Factor1:10
  • Last Split Date2020-09-08
  • Fiscal Year EndDecember
  • IPO Date2014-02-05
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://biocept.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 6.01
  • Price/Book (Most Recent Quarter) 3.77
  • Enterprise Value Revenue 6.18
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.40
  • Profit Margin -237%
  • Operating Margin -215%
  • Return on Assets -61%
  • Return on Equity -175%
  • Revenue 10.73 million
  • Earnings Per Share -$2.63
  • Revenue Per Share $1
  • Gross Profit -5448954
  • Quarterly Earnings Growth 330.7%
View More

Highlights

  • Market Capitalization 77.7 million
  • EBITDA -22827566
  • PEG Ratio -0.04
  • Analyst Target Price $20
  • Book Value Per Share $1.59
View More

Share Statistics

  • Shares Outstanding 13.4 million
  • Shares Float 13.39 million
  • % Held by Insiders 2%
  • % Held by Institutions 14.9%
  • Shares Short 388676
  • Shares Short Prior Month 376845
  • Short Ratio 0.73
  • Short % of Float 3%
  • Short % of Shares Outstanding 3%
View More

Technicals

  • Beta 0.85
  • 52 Week High $11.7
  • 52 Week Low $2.49
  • 50 Day Moving Average 6.42
  • 200 Day Moving Average 5.27
View More

Dividends

  • Dividend Date 2020-09-08
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Biocept, Inc (BIOC) Dividend Calendar:

BIOC's last dividend payment was made to shareholders on September 8, 2020.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Biocept, Inc (BIOC) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-12$6.59 million-$0.43-$0.478.51%
2020-06-302020-08-12$917471-$0.50-$0.500%
2020-03-312020-05-13$1.45 million-$1.10
2019-12-312020-03-25$1.78 million-$2.00-$1.00-100%
2019-09-302019-11-13$1.53 million-$2.50-$2.707.41%
2019-06-302019-08-12$1.19 million-$3.80-$5.6032.14%
2019-03-312019-05-08$1.02 million-$6.10
2018-12-312019-03-28$859526-$14.30-$10.60-34.91%
2018-09-302018-11-13$761591-$24.20-$17.80-35.96%
2018-06-302018-08-14$822238-$27.00-$21.00-28.57%
2018-03-312018-05-15$806943-$33.00-$30.00-10%
2017-12-312018-03-28$996000-$54.00-$42.00-28.57%
2017-09-302017-11-09$1.11 million-$60.00-$57.00-5.26%
2017-06-302017-08-10$1.28 million-$63.00-$54.00-16.67%
2017-03-312017-05-11$1.68 million-$63.00-$66.004.55%
2016-12-312017-03-07$1.29 million-$81.00-$102.0020.59%
2016-09-302016-11-09$1.05 million-$171.00-$178.504.2%
2016-06-302016-08-02$663000-$180.00-$198.009.09%
2016-03-312016-05-12$221000-$225.00-$211.50-6.38%
2015-12-312016-03-09$218000-$216.00-$234.007.69%
2015-09-302015-11-05$165000-$0.72-$0.66-9.09%
2015-06-302015-08-10$77000-$0.66-$0.694.35%
2015-03-312015-05-12$150000-$1.11-$1.8339.34%
2014-12-312015-03-09$75000-$2.61-$2.651.51%
2014-09-302014-11-13$10000-$2.61-$2.44-6.97%
2014-06-302014-08-08$20000-$60.30-$70.2014.1%
2014-03-312014-05-14$28000-$176.40-$81.90-115.38%
2013-12-312014-02-26$19000-$12,210.60

Biocept, Inc (BIOC) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Research Development 1.09 million 1.59 million 1.31 million 1.16 million 1.16 million
Income Before Tax -4.88 million -6.49 million -8.34 million -5.71 million -5.69 million
Selling General Administrative 4.46 million 3.24 million 3.37 million 3.4 million 3.16 million
Gross Profit 726774 -1.6 million -1.5 million -1.09 million -1.3 million
Ebit -4.82 million -6.25 million -8.09 million -5.65 million -5.63 million
Operating Income -4.82 million -6.43 million -6.18 million -5.65 million -5.63 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue 6.59 million 917471 1.45 million 1.78 million 1.53 million
Cost of Revenue 5.86 million 2.52 million 2.95 million 2.87 million 2.83 million
Total Other Income Expense Net N/A N/A -2.1 million -62408 -62028
Net Income From Continuing Operations -4.88 million -6.49 million -8.34 million -5.71 million -5.69 million
Net Income Applicable to Common Shares -4.88 million -6.49 million N/A -5.74 million -5.69 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A -16950 -18507 N/A N/A
Change to Liabilities N/A N/A N/A N/A N/A
Total Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities N/A 9.27 million 17.49 million N/A N/A
Change to Operating Activities N/A N/A N/A N/A N/A
Change in Cash N/A 2.56 million 12.19 million N/A N/A
Total Cash from Operating Activities N/A -6.69 million -5.28 million N/A N/A
Depreciation N/A 186157 194277 N/A N/A
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A -83948 -175952 N/A N/A
Change to Account Receivables N/A 239680 108181 N/A N/A
Other Cash Flow from Financing Activities N/A N/A N/A N/A N/A
Change to Net Income N/A N/A N/A N/A N/A
Capital Expenditures N/A 16950 18507 N/A N/A
Balance Sheet:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Total Liabailities 11.45 million 6.93 million 7.08 million 6.53 million 6.82 million
Total Stockholder Equity 21.35 million 26.08 million 22.73 million 11.2 million 7.71 million
Other Current Liabilities N/A N/A N/A 5.56 million 5.78 million
Total Assets 32.8 million 33.02 million 29.81 million 17.73 million 14.52 million
Common Stock N/A 26.08 million N/A 11.2 million 7.71 million
Other Current Assets N/A N/A N/A N/A N/A
Retained Earnings N/A -260.55 million -254.06 million N/A N/A
Other Liabilities N/A 1.3 million N/A N/A N/A
Other Assets N/A N/A N/A N/A N/A
Cash 16.86 million 24.05 million 21.49 million 9.3 million 6.54 million
Total Current Liabilities 10.11 million 5.63 million 6.03 million 5.56 million 5.78 million
Other Stockholder Equity N/A N/A N/A N/A N/A
Property, Plant & Equipment N/A 3.96 million N/A 3.84 million 3.94 million
Total Current Assets 28.83 million 29.06 million 26.26 million 13.89 million 10.59 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets N/A 26.08 million N/A 11.2 million 7.71 million
Short Term Investments N/A N/A N/A N/A N/A
Long Term Debt N/A N/A N/A N/A N/A
Inventory 3.32 million 973684 918698 767986 687186
Accounts Payable N/A 1.93 million 2.41 million N/A N/A

Biocept, Inc (BIOC) Chart:

Biocept, Inc (BIOC) News:

Below you will find a list of latest news for Biocept, Inc (BIOC) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Biocept, Inc (BIOC) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest BIOC Trades:

Date Shares Price
Jun 13, 2022 7:37 PM EST600$1.22

Biocept, Inc (BIOC) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-018-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459020031517/0001564590-20-031517-index.htm
2018-10-25UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1044378/000000000018033417/0000000000-18-033417-index.htm
2018-12-06UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1044378/000000000018037296/0000000000-18-037296-index.htm
2019-04-18UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1044378/000000000019007319/0000000000-19-007319-index.htm
2019-11-05UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1044378/000000000019015167/0000000000-19-015167-index.htm
2020-05-06UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1044378/000000000020003957/0000000000-20-003957-index.htm
2019-01-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1044378/000090266419000401/0000902664-19-000401-index.htm
2020-01-15SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1044378/000090266420000221/0000902664-20-000221-index.htm
2018-09-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1044378/000114420418050506/0001144204-18-050506-index.htm
2018-10-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1044378/000119312518298247/0001193125-18-298247-index.htm
2019-01-29S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1044378/000119312519020480/0001193125-19-020480-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1044378/000119312519037581/0001193125-19-037581-index.htm
2019-02-19SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1044378/000119312519044367/0001193125-19-044367-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1044378/000119312520038523/0001193125-20-038523-index.htm
2018-09-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919118050131/0001209191-18-050131-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919118053002/0001209191-18-053002-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919119037991/0001209191-19-037991-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919119037992/0001209191-19-037992-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919119037993/0001209191-19-037993-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919119037994/0001209191-19-037994-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919119038000/0001209191-19-038000-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919119038003/0001209191-19-038003-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919119038008/0001209191-19-038008-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919119038009/0001209191-19-038009-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919119038013/0001209191-19-038013-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919119038017/0001209191-19-038017-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919119038019/0001209191-19-038019-index.htm
2020-04-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919120025320/0001209191-20-025320-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919120035207/0001209191-20-035207-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919120035208/0001209191-20-035208-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919120035209/0001209191-20-035209-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919120035210/0001209191-20-035210-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919120035211/0001209191-20-035211-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919120035212/0001209191-20-035212-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919120036491/0001209191-20-036491-index.htm
2020-08-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919120048504/0001209191-20-048504-index.htm
2020-09-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919120048990/0001209191-20-048990-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919120053916/0001209191-20-053916-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919120053919/0001209191-20-053919-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919120053920/0001209191-20-053920-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919120053923/0001209191-20-053923-index.htm
2020-10-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919120055574/0001209191-20-055574-index.htm
2020-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000120919120055575/0001209191-20-055575-index.htm
2018-09-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1044378/000121390018013113/0001213900-18-013113-index.htm
2019-02-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1044378/000121390019001894/0001213900-19-001894-index.htm
2019-02-19SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1044378/000121390019002749/0001213900-19-002749-index.htm
2020-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1044378/000121390020003185/0001213900-20-003185-index.htm
2020-03-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1044378/000121390020006310/0001213900-20-006310-index.htm
2018-10-03DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000138053618000002/0001380536-18-000002-index.htm
2019-01-03SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1044378/000153561019000012/0001535610-19-000012-index.htm
2019-01-18SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1044378/000153561019000057/0001535610-19-000057-index.htm
2020-01-02SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1044378/000153561020000005/0001535610-20-000005-index.htm
2020-03-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1044378/000153561020000078/0001535610-20-000078-index.htm
2018-09-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1044378/000156459018022886/0001564590-18-022886-index.htm
2018-09-24424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1044378/000156459018023487/0001564590-18-023487-index.htm
2018-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459018023489/0001564590-18-023489-index.htm
2018-10-19S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1044378/000156459018024528/0001564590-18-024528-index.htm
2018-10-19S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1044378/000156459018024533/0001564590-18-024533-index.htm
2018-10-25CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1044378/000156459018025147/0001564590-18-025147-index.htm
2018-10-29424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1044378/000156459018025437/0001564590-18-025437-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459018029313/0001564590-18-029313-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1044378/000156459018029614/0001564590-18-029614-index.htm
2018-11-28S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1044378/000156459018030163/0001564590-18-030163-index.htm
2018-12-10S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1044378/000156459018030702/0001564590-18-030702-index.htm
2018-12-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1044378/000156459018031015/0001564590-18-031015-index.htm
2018-12-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1044378/000156459018031016/0001564590-18-031016-index.htm
2018-12-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1044378/000156459018031052/0001564590-18-031052-index.htm
2018-12-19S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1044378/000156459018031070/0001564590-18-031070-index.htm
2018-12-19CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1044378/000156459018031073/0001564590-18-031073-index.htm
2018-12-19CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1044378/000156459018031074/0001564590-18-031074-index.htm
2018-12-19CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1044378/000156459018031122/0001564590-18-031122-index.htm
2018-12-20CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1044378/000156459018031174/0001564590-18-031174-index.htm
2018-12-20CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1044378/000156459018031176/0001564590-18-031176-index.htm
2018-12-20CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1044378/000156459018031200/0001564590-18-031200-index.htm
2019-01-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1044378/000156459019000794/0001564590-19-000794-index.htm
2019-01-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459019000796/0001564590-19-000796-index.htm
2019-02-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1044378/000156459019001974/0001564590-19-001974-index.htm
2019-02-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1044378/000156459019001977/0001564590-19-001977-index.htm
2019-02-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1044378/000156459019001979/0001564590-19-001979-index.htm
2019-02-11424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1044378/000156459019002442/0001564590-19-002442-index.htm
2019-03-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1044378/000156459019008062/0001564590-19-008062-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459019008094/0001564590-19-008094-index.htm
2019-03-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459019009891/0001564590-19-009891-index.htm
2019-03-2910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1044378/000156459019009914/0001564590-19-009914-index.htm
2019-04-10S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1044378/000156459019011262/0001564590-19-011262-index.htm
2019-04-17S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1044378/000156459019011765/0001564590-19-011765-index.htm
2019-04-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1044378/000156459019012026/0001564590-19-012026-index.htm
2019-04-23424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1044378/000156459019012363/0001564590-19-012363-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1044378/000156459019013999/0001564590-19-013999-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459019017258/0001564590-19-017258-index.htm
2019-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1044378/000156459019018972/0001564590-19-018972-index.htm
2019-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459019020661/0001564590-19-020661-index.htm
2019-06-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459019022873/0001564590-19-022873-index.htm
2019-07-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459019025187/0001564590-19-025187-index.htm
2019-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459019031490/0001564590-19-031490-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1044378/000156459019031999/0001564590-19-031999-index.htm
2019-08-15S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1044378/000156459019032201/0001564590-19-032201-index.htm
2019-09-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459019035763/0001564590-19-035763-index.htm
2019-11-04S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1044378/000156459019039452/0001564590-19-039452-index.htm
2019-11-08S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1044378/000156459019042302/0001564590-19-042302-index.htm
2019-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459019043236/0001564590-19-043236-index.htm
2019-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1044378/000156459019043276/0001564590-19-043276-index.htm
2019-11-15S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1044378/000156459019043650/0001564590-19-043650-index.htm
2019-12-05S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1044378/000156459019045290/0001564590-19-045290-index.htm
2019-12-04CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1044378/000156459019045294/0001564590-19-045294-index.htm
2019-12-04CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1044378/000156459019045295/0001564590-19-045295-index.htm
2019-12-06S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1044378/000156459019045408/0001564590-19-045408-index.htm
2019-12-11424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1044378/000156459019045675/0001564590-19-045675-index.htm
2019-12-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459019045680/0001564590-19-045680-index.htm
2020-01-09424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1044378/000156459020000553/0001564590-20-000553-index.htm
2020-01-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459020000554/0001564590-20-000554-index.htm
2020-03-02424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1044378/000156459020008203/0001564590-20-008203-index.htm
2020-03-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459020008453/0001564590-20-008453-index.htm
2020-03-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1044378/000156459020008810/0001564590-20-008810-index.htm
2020-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459020009001/0001564590-20-009001-index.htm
2020-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459020012824/0001564590-20-012824-index.htm
2020-03-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1044378/000156459020013670/0001564590-20-013670-index.htm
2020-04-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459020016309/0001564590-20-016309-index.htm
2020-04-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1044378/000156459020016752/0001564590-20-016752-index.htm
2020-04-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459020016756/0001564590-20-016756-index.htm
2020-04-20PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1044378/000156459020017334/0001564590-20-017334-index.htm
2020-04-24S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1044378/000156459020018551/0001564590-20-018551-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1044378/000156459020019429/0001564590-20-019429-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459020025074/0001564590-20-025074-index.htm
2020-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1044378/000156459020025525/0001564590-20-025525-index.htm
2020-05-21DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1044378/000156459020026579/0001564590-20-026579-index.htm
2020-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459020028516/0001564590-20-028516-index.htm
2020-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459020028904/0001564590-20-028904-index.htm
2020-06-10DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1044378/000156459020028915/0001564590-20-028915-index.htm
2020-07-018-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459020031517/0001564590-20-031517-index.htm
2020-07-13DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1044378/000156459020032267/0001564590-20-032267-index.htm
2020-07-16DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1044378/000156459020032493/0001564590-20-032493-index.htm
2020-08-048-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459020036169/0001564590-20-036169-index.htm
2020-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459020039695/0001564590-20-039695-index.htm
2020-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1044378/000156459020040053/0001564590-20-040053-index.htm
2020-08-218-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459020040957/0001564590-20-040957-index.htm
2020-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459020042651/0001564590-20-042651-index.htm
2020-09-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459020044404/0001564590-20-044404-index.htm
2020-10-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1044378/000156459020047017/0001564590-20-047017-index.htm
2019-03-29DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000177199419000001/0001771994-19-000001-index.htm
2019-06-06DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1044378/000177651219000001/0001776512-19-000001-index.htm
2018-10-29EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1044378/999999999518002746/9999999995-18-002746-index.htm
2019-02-07EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1044378/999999999519000116/9999999995-19-000116-index.htm
2019-04-22EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1044378/999999999519000787/9999999995-19-000787-index.htm
2019-12-09EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1044378/999999999519002762/9999999995-19-002762-index.htm
2020-05-08EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1044378/999999999520001095/9999999995-20-001095-index.htm

Biocept, Inc (BIOC) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biocept, Inc (BIOC). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 2%
Institutional Ownership: 1490%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-06-12DAVID F HALEDirectorSell445.000.55246.75112.00https://www.sec.gov/Archives/edgar/data/1044378/000120919120036491/0001209191-20-036491-index.htm
2020-06-12DAVID F HALEDirectorSell159.000.5688.693,477.00https://www.sec.gov/Archives/edgar/data/1044378/000120919120036491/0001209191-20-036491-index.htm
2020-06-12DAVID F HALEDirectorSell556.000.56308.58867.00https://www.sec.gov/Archives/edgar/data/1044378/000120919120036491/0001209191-20-036491-index.htm